Updates are available Correction dated 2018-11-12

Article History

First Online: 3 August 2018

Change Date: 12 November 2018

Change Type: Correction

Change Details: Page 856: Fig. 6 was an incorrect duplication of Fig. 5. The correct figure is given below.

Compliance with Ethical Standards

:

: The studies summarized in this report were supported by Alzheon, Inc. Funding to cover the cost of open access to this article was provided by Alzheon, Inc.

: John A. Hey, Petr Kocis, Susan Abushakra, Aidan Power, and Martin Tolar are employees of Alzheon, Inc., and own Alzheon stock options. Jeremy Y. Yu serves as a consultant to Alzheon and owns Alzheon stock options. Jakub Hort and Martin Vyhnálek are independent clinical investigators who collaborated on the study. Dr. Jakub Hort is a member of the Alzheon Scientific Advisory Board and owns Alzheon stock options.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

: Drug naïve subjects provided informed consent in accordance with the Czech Republic ethical guidelines.